NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.

Autor: Thompson JA; 1Fred Hutchinson Cancer Center., Schneider BJ; 2University of Michigan Rogel Cancer Center., Brahmer J; 3Johns Hopkins Kimmel Cancer Center., Zaid MA; 4Indiana University Melvin and Bren Simon Comprehensive Cancer Center., Achufusi A; 5University of Wisconsin Carbone Cancer Center., Armand P; 6Dana-Farber Cancer Institute., Berkenstock MK; 3Johns Hopkins Kimmel Cancer Center., Bermas B; 7UT Southwestern Simmons Comprehensive Cancer Center., Braaten T; 8Huntsman Cancer Institute at the University of Utah., Budde LE; 9City of Hope National Medical Center., Chokshi S; 10The University of Tennessee Health Science Center., Crees ZD; 11Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine., Davies M; 12Yale Cancer Center/Smilow Cancer Hospital., Deng C; 13Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Gesthalter Y; 14UCSF Helen Diller Family Comprehensive Cancer Center., Jain M; 15Moffitt Cancer Center., Jain P; 16Roswell Park Comprehensive Cancer Center., Jallouk A; 17Vanderbilt-Ingram Cancer Center., Kaffenberger BH; 18The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Khalil M; 19O'Neal Comprehensive Cancer Center at UAB., Lechner MG; 20UCLA Jonsson Comprehensive Cancer Center., Li T; 21UC Davis Comprehensive Cancer Center., Marr A; 22Fred & Pamela Buffett Cancer Center., McGettigan S; 23Abramson Cancer Center at the University of Pennsylvania., McPherson J; 8Huntsman Cancer Institute at the University of Utah., Medina T; 24University of Colorado Cancer Center., Mohindra NA; 25Robert H. Lurie Comprehensive Cancer Center of Northwestern University., Olszanski AJ; 26Fox Chase Cancer Center., Oluwole O; 17Vanderbilt-Ingram Cancer Center., Patel SP; 27UC San Diego Moores Cancer Center., Prosek J; 18The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Reddy S; 28Stanford Cancer Institute., Reid P; 29The UChicago Medicine Comprehensive Cancer Center., Ryan J; 30Patient Advocate., Ryder M; 31Mayo Clinic Comprehensive Cancer Center., Salman H; 4Indiana University Melvin and Bren Simon Comprehensive Cancer Center., Santomasso B; 32Memorial Sloan Kettering Cancer Center., Shofer S; 33Duke Cancer Institute., Sosman JA; 17Vanderbilt-Ingram Cancer Center., Wang Y; 34The University of Texas MD Anderson Cancer Center., Zaha VG; 7UT Southwestern Simmons Comprehensive Cancer Center., Zucker S; 35Dana-Farber/Brigham and Women's Cancer Center | Mass General Cancer Center., Lyons M; 36National Comprehensive Cancer Network., Awotiwon A; 36National Comprehensive Cancer Network., Hang L; 36National Comprehensive Cancer Network.

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Nov; Vol. 22 (9), pp. 582-592.

Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report.

Autor: Mojarad BA; Cytogenetics and Molecular Pathology Lab, Division of Lab and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine in Saint Louis, MO, USA. Electronic address: bahareh@wustl.edu., Crees ZD; Division of Oncology, Department of Medicine, Washington University School of Medicine in Saint Louis, MO, USA., Schroeder MC; Cytogenetics and Molecular Pathology Lab, Division of Lab and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine in Saint Louis, MO, USA., Xiang Z; Division of Oncology, Department of Medicine, Washington University School of Medicine in Saint Louis, MO, USA., Vader J; Cardiovascular Division, Department of Medicine, Washington University School of Medicine in Saint Louis, MO, USA., Sina J; Division of Anatomic and Molecular Pathology, Department of Pathology and Immunology, Washington University School of Medicine in Saint Louis, MO, USA., Jacoby M; Division of Oncology, Department of Medicine, Washington University School of Medicine in Saint Louis, MO, USA., Frater JL; Division of Anatomic and Molecular Pathology, Department of Pathology and Immunology, Washington University School of Medicine in Saint Louis, MO, USA., Duncavage EJ; Division of Anatomic and Molecular Pathology, Department of Pathology and Immunology, Washington University School of Medicine in Saint Louis, MO, USA., Spencer DH; Division of Oncology, Department of Medicine, Washington University School of Medicine in Saint Louis, MO, USA., Lavine K; Cardiovascular Division, Department of Medicine, Washington University School of Medicine in Saint Louis, MO, USA., Neidich JA; Cytogenetics and Molecular Pathology Lab, Division of Lab and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine in Saint Louis, MO, USA; Department of Pediatrics, Washington University School of Medicine in Saint Louis, MO, USA., Amarillo I; Cytogenetics and Molecular Pathology Lab, Division of Lab and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine in Saint Louis, MO, USA.

Publikováno v: Cancer genetics [Cancer Genet] 2024 Jan; Vol. 280-281, pp. 1-5. Date of Electronic Publication: 2023 Nov 29.

Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor.

Autor: Crees ZD; Division of Oncology, Washington University School of Medicine, St. Louis, MO., Rettig MP; Division of Oncology, Washington University School of Medicine, St. Louis, MO., Bashey A; Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA., Devine SM; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, MN., Jaglowski S; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Wan F; Division of Oncology, Washington University School of Medicine, St. Louis, MO., Zhou A; Division of Oncology, Washington University School of Medicine, St. Louis, MO., Harding M; Division of Oncology, Washington University School of Medicine, St. Louis, MO., Vainstein-Haras A; BioLineRx Ltd, Modi'in, Israel., Sorani E; BioLineRx Ltd, Modi'in, Israel., Gliko-Kabir I; BioLineRx Ltd, Modi'in, Israel., Grossman BJ; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO., Westervelt P; Division of Oncology, Washington University School of Medicine, St. Louis, MO., DiPersio JF; Division of Oncology, Washington University School of Medicine, St. Louis, MO., Uy GL; Division of Oncology, Washington University School of Medicine, St. Louis, MO.

Publikováno v: Blood advances [Blood Adv] 2023 Sep 26; Vol. 7 (18), pp. 5210-5214.

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.

Autor: Crees ZD; Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA. zcrees@wustl.edu., Rettig MP; Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Jayasinghe RG; Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Stockerl-Goldstein K; Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Larson SM; Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA, USA., Arpad I; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Milone GA; Unità di Trapianto Emopoietico, Azienda Ospedaliero Universitaria 'Policlinico-San Marco', Catania, Italy., Martino M; Unit of Stem Cell Transplantation and Cellular Therapies, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy., Stiff P; Loyola University Medical Center, Maywood, CA, USA., Sborov D; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA., Pereira D; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, USA., Micallef I; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Moreno-Jiménez G; Department of Hematology, Ramon y Cajal University Hospital, Madrid, Spain., Mikala G; Center Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary., Coronel MLP; Hospital University 12 De Octubre, Madrid, Spain., Holtick U; Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Hiemenz J; Division of Hematology-Oncology, University of Florida, Gainesville, FL, USA., Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hardy N; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA., Latif T; Division of Hematology-Oncology, University of Cincinnati, Cincinnati, OH, USA., García-Cadenas I; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Vainstein-Haras A; BioLineRx, Ltd., Modi'in, Israel., Sorani E; BioLineRx, Ltd., Modi'in, Israel., Gliko-Kabir I; BioLineRx, Ltd., Modi'in, Israel., Goldstein I; BioLineRx, Ltd., Modi'in, Israel., Ickowicz D; BioLineRx, Ltd., Modi'in, Israel., Shemesh-Darvish L; BioLineRx, Ltd., Modi'in, Israel., Kadosh S; StatExcellence, Ltd., Kyriat Mozkin, Israel., Gao F; Division of Public Health Sciences, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Schroeder MA; Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Vij R; Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., DiPersio JF; Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.

Publikováno v: Nature medicine [Nat Med] 2023 Apr; Vol. 29 (4), pp. 869-879. Date of Electronic Publication: 2023 Apr 17.

COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury.

Autor: Crees ZD; School of Medicine, Division of Oncology, Washington University in St. Louis, Mo. Electronic address: zcrees@wustl.edu., Stockerl-Goldstein K; School of Medicine, Division of Oncology, Washington University in St. Louis, Mo.

Publikováno v: The American journal of medicine [Am J Med] 2022 Apr; Vol. 135 Suppl 1, pp. S49-S52. Date of Electronic Publication: 2022 Jan 23.